195 related articles for article (PubMed ID: 37160841)
1. Parathyroid carcinoma: molecular therapeutic targets.
Marini F; Giusti F; Palmini G; Aurilia C; Donati S; Brandi ML
Endocrine; 2023 Sep; 81(3):409-418. PubMed ID: 37160841
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma.
Cardoso L; Stevenson M; Thakker RV
Hum Mutat; 2017 Dec; 38(12):1621-1648. PubMed ID: 28881068
[TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor gene mutation in a patient with a history of hyperparathyroidism-jaw tumor syndrome and healed generalized osteitis fibrosa cystica: a case report and genetic pathophysiology review.
Parfitt J; Harris M; Wright JM; Kalamchi S
J Oral Maxillofac Surg; 2015 Jan; 73(1):194.e1-9. PubMed ID: 25511968
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Profiling and Molecular Mechanisms in Hyperparathyroidism-jaw Tumor Syndrome.
Tora R; Welch J; Sun J; Agarwal SK; Bell DA; Merino M; Weinstein LS; Simonds WF; Jha S
J Clin Endocrinol Metab; 2023 Nov; 108(12):3165-3177. PubMed ID: 37339334
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel CDC73 gene mutation in a hyperparathyrodism-jaw tumor patient affected by parathyroid carcinoma in the absence of somatic loss of heterozygosity.
Ciuffi S; Cianferotti L; Nesi G; Luzi E; Marini F; Giusti F; Zonefrati R; Gronchi G; Perigli G; Brandi ML
Endocr J; 2019 Apr; 66(4):319-327. PubMed ID: 30799315
[TBL] [Abstract][Full Text] [Related]
6. Parathyroid carcinoma.
Salcuni AS; Cetani F; Guarnieri V; Nicastro V; Romagnoli E; de Martino D; Scillitani A; Cole DEC
Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):877-889. PubMed ID: 30551989
[TBL] [Abstract][Full Text] [Related]
7. Genetics and Epigenetics of Parathyroid Carcinoma.
Marini F; Giusti F; Palmini G; Perigli G; Santoro R; Brandi ML
Front Endocrinol (Lausanne); 2022; 13():834362. PubMed ID: 35282432
[TBL] [Abstract][Full Text] [Related]
8. A family case report of parathyroid carcinoma associated with
Gu Y; Ye Y; Shu H; Chang L; Xie Y; Li F; Zhu T; Liu M; He Q
Front Endocrinol (Lausanne); 2024; 15():1330185. PubMed ID: 38348418
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes of Parathyroidectomy in Hyperparathyroidism-Jaw Tumor Syndrome: Analysis of Five Families with CDC73 Mutations.
Iacobone M; Camozzi V; Mian C; Pennelli G; Pagetta C; Casal Ide E; Masi G; Zovato S; Torresan F
World J Surg; 2020 Feb; 44(2):508-516. PubMed ID: 31493194
[TBL] [Abstract][Full Text] [Related]
10. Mice deleted for cell division cycle 73 gene develop parathyroid and uterine tumours: model for the hyperparathyroidism-jaw tumour syndrome.
Walls GV; Stevenson M; Lines KE; Newey PJ; Reed AAC; Bowl MR; Jeyabalan J; Harding B; Bradley KJ; Manek S; Chen J; Wang P; Williams BO; Teh BT; Thakker RV
Oncogene; 2017 Jul; 36(28):4025-4036. PubMed ID: 28288139
[TBL] [Abstract][Full Text] [Related]
11. Update on parathyroid carcinoma.
Cetani F; Pardi E; Marcocci C
J Endocrinol Invest; 2016 Jun; 39(6):595-606. PubMed ID: 27001435
[TBL] [Abstract][Full Text] [Related]
12. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid cancer: An update.
Rodrigo JP; Hernandez-Prera JC; Randolph GW; Zafereo ME; Hartl DM; Silver CE; Suárez C; Owen RP; Bradford CR; Mäkitie AA; Shaha AR; Bishop JA; Rinaldo A; Ferlito A
Cancer Treat Rev; 2020 Jun; 86():102012. PubMed ID: 32247225
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid cancer.
Sharretts JM; Kebebew E; Simonds WF
Semin Oncol; 2010 Dec; 37(6):580-90. PubMed ID: 21167377
[TBL] [Abstract][Full Text] [Related]
15. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
[TBL] [Abstract][Full Text] [Related]
16. Familial isolated primary hyperparathyroidism/hyperparathyroidism-jaw tumour syndrome caused by germline gross deletion or point mutations of CDC73 gene in Chinese.
Kong J; Wang O; Nie M; Shi J; Hu Y; Jiang Y; Li M; Xia W; Meng X; Xing X
Clin Endocrinol (Oxf); 2014 Aug; 81(2):222-30. PubMed ID: 24716902
[TBL] [Abstract][Full Text] [Related]
17. Hyperparathyroidism-jaw tumor syndrome: Results of operative management.
Mehta A; Patel D; Rosenberg A; Boufraqech M; Ellis RJ; Nilubol N; Quezado MM; Marx SJ; Simonds WF; Kebebew E
Surgery; 2014 Dec; 156(6):1315-24; discussion 1324-5. PubMed ID: 25444225
[TBL] [Abstract][Full Text] [Related]
18. Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family.
Cascón A; Huarte-Mendicoa CV; Javier Leandro-García L; Letón R; Suela J; Santana A; Costa MB; Comino-Méndez I; Landa I; Sánchez L; Rodríguez-Antona C; Cigudosa JC; Robledo M
Genes Chromosomes Cancer; 2011 Nov; 50(11):922-9. PubMed ID: 21837707
[TBL] [Abstract][Full Text] [Related]
19. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
[TBL] [Abstract][Full Text] [Related]
20. Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors.
Newey PJ; Bowl MR; Cranston T; Thakker RV
Hum Mutat; 2010 Mar; 31(3):295-307. PubMed ID: 20052758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]